ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
EHA 2022 Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Surpasses Chemoimmunotherapy in Frontline CLL: Phase III GAIA/CLL13 Trial Updates
By
ecancer
FEATURING
Barbara Eichhorst
By
ecancer
FEATURING
Barbara Eichhorst
Login to view comments.
Click here to Login
